Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

307 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
CD4/CD8 ratio in pregnant women with HIV and its association with pregnancy outcome: data from a national study in Italy.
Floridia M, Pinnetti C, Masuelli G, Spinillo A, Savasi VM, Liuzzi G, Degli Antoni AM, Sansone M, Guaraldi G, Dalzero S, Maso G, Francisci D, Sterrantino G, Ravizza M, Tamburrini E; Italian Group on Surveillance of Antiretroviral Treatment in Pregnancy. Floridia M, et al. Among authors: francisci d. Infection. 2021 Oct;49(5):955-964. doi: 10.1007/s15010-021-01619-4. Epub 2021 May 8. Infection. 2021. PMID: 33963983
A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients with advanced disease.
Floridia M, Bucciardini R, Ricciardulli D, Fragola V, Pirillo MF, Weimer LE, Tomino C, Giannini G, Galluzzo CM, Andreotti M, Cargnel A, Alberici F, De Rienzo B, Leoncini F, Fiaccadori F, Francisci D, Grillone W, Ortona L, Piazza M, Scalzini A, Nigra E, Tumietto F, Vella S. Floridia M, et al. Among authors: francisci d. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 Jan 1;20(1):11-9. doi: 10.1097/00042560-199901010-00002. J Acquir Immune Defic Syndr Hum Retrovirol. 1999. PMID: 9928724 Clinical Trial.
Raltegravir plasma concentrations in treatment-experienced patients receiving salvage regimens based on raltegravir with and without maraviroc coadministration.
Baroncelli S, Villani P, Weimer LE, Ladisa N, Francisci D, Tommasi C, Vullo V, Preziosi R, Cicalini S, Cusato M, Galluzzo C, Floridia M, Regazzi M; ISS-NIA Group. Baroncelli S, et al. Among authors: francisci d. Ann Pharmacother. 2010 May;44(5):838-43. doi: 10.1345/aph.1M688. Epub 2010 Apr 6. Ann Pharmacother. 2010. PMID: 20371753 Clinical Trial.
Pregnancy outcomes in women with advanced HIV infection in Italy.
Baroncelli S, Tamburrini E, Ravizza M, Pinnetti C, Dalzero S, Scatà M, Crepaldi A, Liuzzi G, Molinari A, Vimercati A, Maccabruni A, Francisci D, Rubino E, Floridia M; Italian Group On Surveillance On Antiretroviral Treatment In Pregnancy. Baroncelli S, et al. Among authors: francisci d. AIDS Patient Care STDS. 2011 Nov;25(11):639-45. doi: 10.1089/apc.2011.0172. Epub 2011 Sep 23. AIDS Patient Care STDS. 2011. PMID: 21942814 Free PMC article.
Evolution of proviral DNA HIV-1 tropism under selective pressure of maraviroc-based therapy.
Baroncelli S, Galluzzo CM, Weimer LE, Pirillo MF, Volpe A, Mercuri A, Cavalli A, Fragola V, Monno L, Degli Antoni A, Ladisa N, Francisci D, Bucciardini R, Floridia M. Baroncelli S, et al. Among authors: francisci d. J Antimicrob Chemother. 2012 Jun;67(6):1479-85. doi: 10.1093/jac/dks055. Epub 2012 Feb 23. J Antimicrob Chemother. 2012. PMID: 22361986 Free PMC article.
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.
Colafigli M, Torti C, Trecarichi EM, Albini L, Rosi A, Micheli V, Manca N, Penco G, Bruzzone B, Punzi G, Corsi P, Parruti G, Bagnarelli P, Monno L, Gonnelli A, Cauda R, Di Giambenedetto S; ARCA, UCSC and Brescia HIV resistance study groups. Colafigli M, et al. Clin Microbiol Infect. 2012 Aug;18(8):E299-304. doi: 10.1111/j.1469-0691.2012.03847.x. Epub 2012 Apr 27. Clin Microbiol Infect. 2012. PMID: 22536753 Free PMC article.
Virological failure at one year in triple-class experienced patients switching to raltegravir-based regimens is not predicted by baseline factors.
Bucciardini R, D'Ettorre G, Baroncelli S, Ceccarelli G, Parruti G, Weimer LE, Fragola V, Galluzzo CM, Pirillo MF, Lucattini S, Bellagamba R, Francisci D, Ladisa N, Degli Antoni A, Guaraldi G, Manconi PE, Vullo V, Preziosi R, Cirioni O, Verucchi G, Floridia M; ISS-NIA study group. Bucciardini R, et al. Among authors: d ettorre g, francisci d. Int J STD AIDS. 2012 Jul;23(7):459-63. doi: 10.1258/ijsa.2012.011391. Int J STD AIDS. 2012. PMID: 22843997 Clinical Trial.
307 results